The FDA Advisory Panel Peptide Vote: What Actually Happened, and What It Means for Your Practice
On July 23-24, 2026, the FDA's Pharmacy Compounding Advisory Committee voted to recommend BPC-157, KPV, TB-500, and MOTS-c for compounding pharmacy production. The votes are non-binding, no regulatory change has...
